Wu & Hakami investigating COVID-19 therapies

Yuntao Wu, Professor, Molecular and Microbiology, and Ramin Hakami, Associate Professor, School of Systems Biology, are conducting studies of COVID-19 therapies. Recent work from several independent groups has demonstrated that K18-hACE2 transgenic mice serve as an appropriate animal model for studying COVID-19. Published research has shown that ACE2 is the human cell entry receptor for…

Consenting for treatment in advance to reduce leaving the hospital against medical advice among patients with addiction – Experts debate pros and cons

January 22, 2021 – Patients with substance use disorders (SUDs) being treated for serious medical conditions are more likely to leave the hospital against medical advice (AMA) than those without addiction. A special type of contract with healthcare providers might enable patients to consent in advance to life-saving medical care – even if they later…

Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announce

A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical companies, and two…

Research shows preference for male children is declining in Bangladesh

Research from the University of Kent has demonstrated a decline in ‘son preference’ by women of childbearing age in Bangladesh. However, the study also shows that fertility decisions are still influenced according to son preference. The paper, ‘Is son preference disappearing from Bangladesh?’, surveyed a nationally representative sample of Bangladeshi women of childbearing age, born…

U.S. Vaccine Supply: What to Know

Demand for vaccines is skyrocketing as the United States grapples with a record death toll from Covid-19 and the threat of new, more contagious variants. After a slow start in December, many states and cities have quickly ramped up vaccine delivery, widening access to larger groups of people and setting up mass testing sites. But…

Why Biden Inherited a Covid-19 Vaccine Supply Unlikely to Grow Before April

Johnson & Johnson is also in preliminary talks with Merck, a major American pharmaceutical company, about using its production lines, one of several ideas that federal health officials discussed with the Biden transition team. Federal officials are interested in boosting the nation’s vaccine-making power long-term, and Merck’s facilities may be among the few with remaining…